# A Study of the Effectiveness and Safety of Topiramate Monotherapy in Patients With Recently Diagnosed Partial-Onset Seizure

> **NCT00230698** · PHASE3 · COMPLETED · sponsor: **Johnson & Johnson Pharmaceutical Research & Development, L.L.C.** · enrollment: 451 (actual)

## Conditions studied

- Epilepsy
- Epilepsies, Partial
- Seizures

## Interventions

- **DRUG:** topiramate

## Key facts

- **NCT ID:** NCT00230698
- **Lead sponsor:** Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1995-11
- **Primary completion:** —
- **Final completion:** 2002-08
- **Target enrollment:** 451 (ACTUAL)
- **Last updated:** 2010-11-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00230698

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00230698, "A Study of the Effectiveness and Safety of Topiramate Monotherapy in Patients With Recently Diagnosed Partial-Onset Seizure". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00230698. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*